4.66
price down icon5.28%   -0.26
after-market After Hours: 4.62 -0.04 -0.86%
loading

Emergent Biosolutions Inc Stock (EBS) Latest News

pulisher
Mar 26, 2025

Emergent BioSolutions: I See Further Downside Ahead In This Value Trap (NYSE:EBS) - Seeking Alpha

Mar 26, 2025
pulisher
Mar 21, 2025

SEC Form DEFA14A filed by Emergent BioSolutions Inc. - Quantisnow

Mar 21, 2025
pulisher
Mar 21, 2025

Expert Outlook: Emergent BioSolutions Through The Eyes Of 5 Analysts - Benzinga

Mar 21, 2025
pulisher
Mar 21, 2025

Benign Growth For Emergent BioSolutions Inc. (NYSE:EBS) Underpins Stock's 31% Plummet - Simply Wall St

Mar 21, 2025
pulisher
Mar 21, 2025

Emergent BioSolutions New Hire Equity Grant Under NYSE Rule 303A.08 - The Manila Times

Mar 21, 2025
pulisher
Mar 20, 2025

Just Awarded: Emergent BioSolutions Grants Major 72,882 Share Package to Strategic New Hire - StockTitan

Mar 20, 2025
pulisher
Mar 20, 2025

Emergent BioSolutions: Attractive Biotech With Proven Business Clouded By Washington Funding Issues - Seeking Alpha

Mar 20, 2025
pulisher
Mar 20, 2025

Hikma announces Health Canada approval of KLOXXADO® (naloxone HCl) Nasal Spray 8 mg - The Manila Times

Mar 20, 2025
pulisher
Mar 20, 2025

Breakthrough: New High-Dose Naloxone Spray Gets Health Canada Green Light as Overdose Crisis Persists - StockTitan

Mar 20, 2025
pulisher
Mar 20, 2025

Syngene concludes acquisition of biologics manufacturing facility from Emergent BioSolutions - Medical Dialogues

Mar 20, 2025
pulisher
Mar 19, 2025

Emergent BioSolutions Finalizes Sale of Baltimore-Bayview Manufacturing Site to Syngene International - citybiz

Mar 19, 2025
pulisher
Mar 19, 2025

Syngene concludes the acquisition of Biologics Manufacturing Facility from Emergent BioSolutions Inc. - Equity Bulls

Mar 19, 2025
pulisher
Mar 19, 2025

Emergent BioSolutions sells Baltimore facility to Syngene By Investing.com - Investing.com South Africa

Mar 19, 2025
pulisher
Mar 19, 2025

Emergent BioSolutions Completes Sale of Baltimore-Bayview Facility to Syngene International - Marketscreener.com

Mar 19, 2025
pulisher
Mar 19, 2025

Emergent BioSolutions sells Baltimore facility to Syngene - Investing.com India

Mar 19, 2025
pulisher
Mar 19, 2025

Emergent Biosolutions finalizes sale of Baltimore-Bayview manufacturing site to Syngene International - Marketscreener.com

Mar 19, 2025
pulisher
Mar 19, 2025

Emergent BioSolutions Strategic Win: $36.5M Facility Sale While Securing Future Production Rights - StockTitan

Mar 19, 2025
pulisher
Mar 19, 2025

Emergent BioSolutions secures $27 million in MCM orders By Investing.com - Investing.com Australia

Mar 19, 2025
pulisher
Mar 18, 2025

Emergent BioSolutions secures $27 million in MCM orders - Investing.com

Mar 18, 2025
pulisher
Mar 18, 2025

Emergent BioSolutions Announces Approximately $27 Million in Incremental Sales to Supply International Customers with Five Critical Medical Countermeasure Products - The Manila Times

Mar 18, 2025
pulisher
Mar 18, 2025

Emergent BioSolutions Announces Approximately $27 Million in Incremental Sales to Supply International - EIN News

Mar 18, 2025
pulisher
Mar 18, 2025

Emergent BioSolutions Expands Global Reach with $27M Medical Defense Deal - StockTitan

Mar 18, 2025
pulisher
Mar 14, 2025

India-based Syngene acquires its first US biologics site - Manufacturing Dive

Mar 14, 2025
pulisher
Mar 14, 2025

Emergent BioSolutions to invest in Rocketvax for vaccine developments - MSN

Mar 14, 2025
pulisher
Mar 14, 2025

Emergent BioSolutions to sell Baltimore-Bayview manufacturing site for $36.5M - MSN

Mar 14, 2025
pulisher
Mar 13, 2025

Emergent signs financial investment agreement with Swiss Rockets - Yahoo

Mar 13, 2025
pulisher
Mar 13, 2025

Emergent BioSolutions Reinforces its Commitment to Expanding Access to NARCAN® Nasal Spray by Supporting Organizations with New Opioid Overdose Preparedness Programs - The Manila Times

Mar 13, 2025
pulisher
Mar 13, 2025

Emergent BioSolutions Reinforces its Commitment to Expanding Access to NARCAN® Nasal Spray by ... - The Bakersfield Californian

Mar 13, 2025
pulisher
Mar 13, 2025

First OTC Narcan Program Targets High-Risk Construction Workers to Combat Overdose Crisis - StockTitan

Mar 13, 2025
pulisher
Mar 12, 2025

Emergent BioSolutions director Zoon sells $57,300 in stock By Investing.com - Investing.com Australia

Mar 12, 2025
pulisher
Mar 12, 2025

Emergent BioSolutions director Fowler sells $204,050 in stock By Investing.com - Investing.com Australia

Mar 12, 2025
pulisher
Mar 12, 2025

Emergent BioSolutions director Fowler sells $204,050 in stock - Investing.com India

Mar 12, 2025
pulisher
Mar 12, 2025

Emergent BioSolutions director Zoon sells $57,300 in stock - Investing.com

Mar 12, 2025
pulisher
Mar 12, 2025

Emergent Bio and Rocketvax in investment deal and partnership - The Pharma Letter

Mar 12, 2025
pulisher
Mar 12, 2025

Emergent BioSolutions and Rocketvax Announce Investment Agreement - Contract Pharma

Mar 12, 2025
pulisher
Mar 12, 2025

Emergent Biosolutions And Rocketvax Announce Investment Agreement And Pursuit Of A Strategic Relationship For Next-Generation Product Candidates - Marketscreener.com

Mar 12, 2025
pulisher
Mar 12, 2025

Emergent BioSolutions to Invest in Swiss Rockets, Rocketvax -March 12, 2025 at 08:40 am EDT - Marketscreener.com

Mar 12, 2025
pulisher
Mar 12, 2025

Emergent BioSolutions, Rocketvax announce investment agreement - TipRanks

Mar 12, 2025
pulisher
Mar 12, 2025

Emergent BioSolutions and Rocketvax Ltd Announce Strategic Investment and Partnership to Advance Next-Generation Vaccine Development - Nasdaq

Mar 12, 2025
pulisher
Mar 12, 2025

Emergent BioSolutions and Rocketvax Announce Investment - GlobeNewswire

Mar 12, 2025
pulisher
Mar 12, 2025

Emergent BioSolutions and Rocketvax Announce Investment Agreement and Pursuit of a Strategic Relationship for Next-Generation Product Candidates - GlobeNewswire Inc.

Mar 12, 2025
pulisher
Mar 11, 2025

Rhumbline Advisers Trims Stock Position in Emergent BioSolutions Inc. (NYSE:EBS) - Defense World

Mar 11, 2025
pulisher
Mar 11, 2025

Syngene buys its first manufacturing facility in US for USD36.5 million - Medical Dialogues

Mar 11, 2025
pulisher
Mar 11, 2025

India's Syngene International acquires first US biologics facility for $36.5 mln - Reuters

Mar 11, 2025
pulisher
Mar 10, 2025

Emergent BioSolutions Sells Baltimore Facility to Syngene - TipRanks

Mar 10, 2025
pulisher
Mar 10, 2025

Gaithersburg's Emergent BioSolutions to sell Baltimore plant for $36.5M - The Business Journals

Mar 10, 2025
pulisher
Mar 10, 2025

Drug manufacturer to sell Baltimore plant for $36.5M - The Business Journals

Mar 10, 2025
$10.41
price down icon 3.70%
$33.21
price down icon 0.95%
$96.16
price down icon 0.91%
$8.68
price down icon 1.81%
$113.16
price down icon 0.74%
$131.81
price up icon 0.05%
Cap:     |  Volume (24h):